{"abstract":"The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the (U.S.) Patents and Patent Applications listed in the Supplementary Information section of this notice to NE1 Inc, located at 515 Madison Avenue, 8th Fl. Suite 8096, New York, NY 10022.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2021/10/06/2021-21845.html","cfr_references":[],"citation":"86 FR 55625","comment_url":null,"comments_close_on":"2021-10-21","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the National Cancer Institute's Technology Transfer Center on or before October 21, 2021 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2021-21845","effective_on":null,"end_page":55625,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2021/10/06/2021-21845.xml","html_url":"https://www.federalregister.gov/documents/2021/10/06/2021-21845/prospective-grant-of-an-exclusive-patent-license-personalized-tumor-vaccine-and-use-thereof-for","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2021-21845?publication_date=2021-10-06","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2021-10-06/2021-21845/mods.xml","not_received_for_publication":null,"page_length":1,"page_views":{"count":201,"last_updated":"2026-07-26 08:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2021-10-06/pdf/2021-21845.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2021-21845.pdf?1633437938","publication_date":"2021-10-06","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2021/10/06/2021-21845.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2023-02-28T17:43:19Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":55625,"subtype":null,"title":"Prospective Grant of an Exclusive Patent License: Personalized Tumor Vaccine and Use Thereof for Cancer Immunotherapy","toc_doc":"Personalized Tumor Vaccine and Use Thereof for Cancer Immunotherapy","toc_subject":"Prospective Grant of an Exclusive Patent License:\n","topics":[],"type":"Notice","volume":86}